Mild hyponatremia is associated with an increased risk of death in an ambulatory setting

Kidney International

Volumn 83, Issue 4, 2013, Pages 700-706

  Gankam Kengne, Fabrice ^a   Ayers, Colby ^b   Khera, Amit ^a,b   De Lemos, James ^a,b   Maalouf, Naim M ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

clinical epidemiology; hyponatremia; mortality

Indexed keywords

ANTICONVULSIVE AGENT; C REACTIVE PROTEIN; SEROTONIN UPTAKE INHIBITOR; SODIUM; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CAUCASIAN; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG USE; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; HYPONATREMIA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SODIUM BLOOD LEVEL;

EID: 84875751924     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.459     Document Type: Article

References (32)

1. Adrogué HJ, Madias NE. Hyponatremia. N Engl J Med 2000; 342: 1581-1589.
2. Upadhyay A, Jaber BL, Madias NE. Epidemiology of hyponatremia. Semin Nephrol 2009; 29: 227-238.
3. Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta 2003; 337: 169-172.
4. Klein L, O'Connor CM, Leimberger JD et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure. Circulation 2005; 111: 2454-2460.
5. Kim WR, Biggins SW, Kremers WK et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008; 359: 1018-1026.
6. Zilberberg M, Exuzides A, Spalding J et al. Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med 2008; 8: 16.
7. Kovesdy CP, Lott EH, Lu JL et al. Hyponatremia, hypernatremia and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 2012; 125: 677-684.
8. Renneboog B, Musch W, Vandemergel X et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119: e1-e8.
9. Gankam Kengne F, Andres C, Sattar L et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 2008; 101: 583-588.
10. Verbalis JG, Barsony J, Sugimura Y et al. Hyponatremia-induced osteoporosis. J Bone Miner Res 2010; 25: 554-563.
11. Kinsella S, Moran S, Sullivan MO et al. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol 2010; 5: 275-280.
12. Sajadieh A, Binici Z, Mouridsen MR et al. Mild hyponatremia carries a poor prognosis in community subjects. Am J Med 2009; 122: 679-686.
13. Hoorn EJ, Rivadeneira F, van Meurs JB et al. Mild hyponatremia as a risk factor for fractures: the Rotterdam Study. J Bone Miner Res 2011; 26: 1822-1828.
14. Fenske W, Stö rk S, Koschker AC et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab 2008; 93: 2991-2997.
15. Decaux G. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Semin Nephrol 2009; 29: 239-256.
16. Doshi SM, Shah P, Lei X et al. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis 2012; 59: 222-228.
17. Goldberg A, Hammerman H, Petcherski S et al. Hyponatremia and longterm mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med 2006; 166: 781-786.
18. Whelan B, Bennett K, O'riordan D et al. Serum sodium as a risk factor for in-hospital mortality in acute unselected general medical patients. QJM 2009; 102: 175-182.
19. Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 2009; 122: 857-865.
20. Wald R, Jaber BL, Price LL et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010; 170: 294-302.
21. Decaux G. Is asymptomatic hyponatremia really asymptomatic? Am J Med 2006; 119: S79-S82.
22. Barsony J, Manigrasso MB, Xu Q et al. Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr) 2012 (e-pub ahead of print).
23. Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 2008; 371: 1624-1632.
24. Gross PA, Wagner A, Decaux G. Vaptans are not the mainstay of treatment in hyponatremia: perhaps not yet. Kidney Int 2011; 80: 594-600.
25. Soupart A, Coffernils M, Couturier B et al. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol 2012; 7: 742-747.
26. Victor RG, Haley RW, Willett DL et al. The Dallas Heart Study: a populationbased probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004; 93: 1473-1480.
27. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3241.
28. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470.
29. Abdullah SM, Khera A, Das SR et al. Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study). Am J Cardiol 2005; 96: 1284-1289.
30. Khera A, McGuire DK, Murphy SA et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005; 46: 464-469.
31. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999; 106: 399-403.
32. de Lemos JA, Drazner MH, Omland T et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304: 2503-2512.